Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 5.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
F
FMR LLC
|
8.2M | 14.30% | +432.2K (+5.6%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding8.2M (Q2'26)
Change over 8 quarters+3.8M
Share of the company14.300%
|
||||||
|
AP
Avidity Partners Management LP
13D · 4.9%
|
2.1M | 3.67% | −2.1M (−50.0%) | 2023 | 32.9% | |
|
Shares held by quarter
Peak holding4.2M (Q1'26)
Change over 8 quarters−813.0K
Share of the company3.670%
Disclosed stake13D · 4.9%
|
||||||
28 more super investors behind a free account
See every manager holding Dianthus Therapeutics, Inc. /DE/, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FG
Fidelity Mt. Vernon Street Trust
|
$168M | 1.6M | 2.78% | 0.17% | August 31, 2026 |
|
VT
Vanguard Index Funds
|
$161M | 1.6M | 2.88% | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Dianthus Therapeutics, Inc. /DE/ and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
TK
Tomas Kiselak
5%+ holder
13D · 4.9%
|
2.1M | 3.73% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
PE
Peter Evan Harwin
5%+ holder
13D · 4.9%
|
2.1M | 3.73% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
5 more holders behind a free account
See every insider and 5%+ holder of Dianthus Therapeutics, Inc. /DE/.
Sign up freeLoading...